[HTML][HTML] The key role of phosphate on vascular calcification

M Cozzolino, P Ciceri, A Galassi, M Mangano… - Toxins, 2019 - mdpi.com
Vascular calcification (VC) is common in dialysis and non-dialysis chronic kidney disease
(CKD) patients, even in the early stage of the disease. For this reason, it can be considered …

Chronic kidney disease–mineral and bone disorder (CKD-MBD): current perspectives

B Waziri, R Duarte, S Naicker - International journal of nephrology …, 2019 - Taylor & Francis
Despite the availability of global and regional guidelines to curtail the adverse clinical
outcomes associated with chronic kidney disease–mineral and bone disorder (CKD-MBD) …

[PDF][PDF] Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder

M Fukagawa, K Yokoyama, F Koiwa… - … Apheresis and Dialysis, 2013 - jsdt.or.jp
Masafumi Fukagawa, 1 Keitaro Yokoyama, 1 Fumihiko Koiwa, 1 Masatomo Taniguchi, 1
Tetsuo Shoji, 1 Junichiro James Kazama, 1 Hirotaka Komaba, 1 Ryoichi Ando, 1 Takatoshi …

Blood calcification propensity, cardiovascular events, and survival in patients receiving hemodialysis in the EVOLVE trial

A Pasch, GA Block, M Bachtler, ER Smith… - Clinical Journal of the …, 2017 - journals.lww.com
Results Serum albumin, bicarbonate, HDL cholesterol, and creatinine were the main factors
positively/directly and phosphate was the main factor negatively/inversely associated with T …

Slower progress of aortic valve calcification with vitamin K supplementation: results from a prospective interventional proof-of-concept study

VM Brandenburg, S Reinartz, N Kaesler, T Krüger… - Circulation, 2017 - Am Heart Assoc
Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation | Circulation
Science Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello …

[HTML][HTML] Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

VM Brandenburg, R Kramann, R Koos, T Krüger… - BMC nephrology, 2013 - Springer
Abstract Background Sclerostin is a Wnt pathway antagonist regulating osteoblast activity
and bone turnover. Here, we assessed the potential association of sclerostin with the …

Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells

L Louvet, J Büchel, S Steppan… - Nephrology Dialysis …, 2013 - academic.oup.com
Background Vascular calcification (VC) is prevalent in patients suffering from chronic kidney
disease. Factors promoting calcification include abnormalities in mineral metabolism …

[HTML][HTML] Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients

SR Choi, YK Lee, AJ Cho, HC Park, CH Han, MJ Choi… - PloS one, 2019 - journals.plos.org
Background and aims Malnutrition and inflammation are closely linked to vascular
calcification (VC), the severity of which correlate with adverse outcome. However, there were …

Bone alkaline phosphatase in CKD–mineral bone disorder

S Sardiwal, P Magnusson, DJA Goldsmith… - American journal of …, 2013 - Elsevier
Overall and cardiovascular mortality in patients with chronic kidney disease (CKD) is greatly
increased, without obvious current effective treatments. Mineral and bone disorder (MBD) is …

[HTML][HTML] High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial

M Aoun, M Makki, H Azar, H Matta, DN Chelala - BMC nephrology, 2017 - Springer
Background Vascular calcifications are highly prevalent in hemodialysis patients.
Dephosphorylated-uncarboxylated MGP (dp-ucMGP) was found to increase in vitamin K …